Sign In
Buy GOSS
$0.188
-0.0119 (-5.94%)
At Close: Jun 03, 2026
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of VMW, MESA and GOSS
08:25pm, Thursday, 21'st May 2020
NEW YORK, NY / ACCESSWIRE / May 21, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly-traded companies. Sh
LOS ANGELES, CA / ACCESSWIRE / May 21, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ANAB, GOSS and ZM
10:20am, Thursday, 21'st May 2020
NEW YORK, NY / ACCESSWIRE / May 21, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
LOS ANGELES, CA / ACCESSWIRE / May 20, 2020 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
NEW YORK, May 20, 2020 /PRNewswire via COMTEX/ --
NEW YORK, May 20, 2020 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is...
New York, New York--(Newsfile Corp. - May 20, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Gossamer Bio, Inc. (NASDAQ: GOSS) alleging
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Gossamer Bio, Inc. ("Gossamer" or the "Company")(NASDAQ:GOSS) of the June 2, 2020 deadline to seek the role of lead p
New York, New York--(Newsfile Corp. - May 19, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Gos
LOS ANGELES, CA / ACCESSWIRE / May 19, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
Why Gossamer Bio Stock Is Tumbling Today
04:12pm, Tuesday, 19'th May 2020
Shares of Gossamer Bio (NASDAQ: GOSS) were tumbling 16.4% lower as of 11:55 a.m. EDT on Tuesday. The decline came after the company announced the pricing of a secondary stock offering of more than 9.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS
03:40pm, Tuesday, 19'th May 2020
NEW YORK, NY / ACCESSWIRE / May 19, 2020 / Pomerantz LLP is investigating claims on behalf of investors Gossamer Bio, Inc. ("Gossamer" or the "Company") (NASDAQ:GOSS). Such investors ...
Lawsuits Filed Against GOSS, BBBY and GRPN - Jakubowitz Law Pursues Shareholders Claims
10:20am, Tuesday, 19'th May 2020
NEW YORK, NY / ACCESSWIRE / May 19, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who
Gossamer Bio Announces Pricing of Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
05:24am, Tuesday, 19'th May 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflamm
LOS ANGELES, CA / ACCESSWIRE / May 18, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against Gossamer Bio, Inc. ("Gossamer"
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 18)
ADC Therapeutics SA (NYSE:...
